Neuralink raised $600 million, reaching a $9 billion valuation
Longevity Technology - 28-May-2025The company is still in early stages but attracting strong investor interest
Join the club for FREE to access the whole archive and other member benefits.
The company is still in early stages but attracting strong investor interest
India partnerships and FDA progress boost future income
Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy
Berlin startup freezes bodies, hoping for future revival
Juvenescence expands pipeline and UAE presence with new funding to tackle age-related diseases
Click on resource name for more details.
11-Jun-2025
Summit exploring the Aging Code through AI organised by Longevity Global (Cambridge, MA, USA)
Venture capital fund that invests in life sciences, cancer research, age-related diseases and regenerative medicine
04-Apr-2025 to 25-May-2025
Ground-breaking longevity innovation zone set to transform the Bay Area into the global epicenter of human longevity innovation (Berkeley, CA)
27-Mar-2025
Exploring questions around society’s technological needs of the future with Innovate UK's event (London, UK)
26-Feb-2025
London Longevity online webinar with Professor Ronjon Nag
Great to see a startup willing to explicitly state they are treating ageing itself as a disease
Adrian reviews a range of finalists trying to track cancer, blood oxygenation, retinal scans, and cardiac health
Skincare product R&D budgets exceed the National Institute on Aging's budget - let's get it focussed on real anti-aging science